Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Acacia Pharma Group plc
  6. Summary
    ACPH   GB00BYWF9Y76

ACACIA PHARMA GROUP PLC

(ACPH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
2.165(c) 2.2(c) 2.19(c) 2.15(c) 2.15(c) Last
207 116 211 472 97 245 135 329 156 902 Volume
-3.13% +1.62% -0.45% -1.83% 0.00% Change
More quotes
Financials
Sales 2021 5,13 M 7,24 M 7,24 M
Net income 2021 -36,9 M -52,0 M -52,0 M
Net cash position 2021 2,67 M 3,76 M 3,76 M
P/E ratio 2021 -4,91x
Yield 2021 -
Sales 2022 30,1 M 42,5 M 42,5 M
Net income 2022 -29,5 M -41,6 M -41,6 M
Net Debt 2022 25,4 M 35,9 M 35,9 M
P/E ratio 2022 -6,22x
Yield 2022 -
Capitalization 184 M 259 M 259 M
EV / Sales 2021 35,3x
EV / Sales 2022 6,95x
Nbr of Employees 72
Free-Float 62,6%
More Financials
Company
Acacia Pharma Group plc specializes in the research and development of supportive care medicines. The products are intended to support the side effects of anti-cancer treatments (including nausea and vomiting drugs). At the end of 2020, the group had a portfolio of 3 products, including 1 in phase II of clinical development (APD403; treatment of chemically induced nausea and vomiting) and 2 in pre-launch phase:... 
Sector
Pharmaceuticals
Calendar
06/28 | 09:00amShareholder meeting
More about the company
Ratings of Acacia Pharma Group plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ACACIA PHARMA GROUP PLC
06/01ACACIA PHARMA  : Corporate Presentation – Jefferies Healthcare Conference,..
PU
05/25ACACIA PHARMA GROUP PLC : Notice of Annual General Meeting
AQ
05/25ACACIA PHARMA  : to Participate in Jefferies Virtual Healthcare Conference
AQ
05/19ACACIA PHARMA  : Appoints Lilly Official as New Chief Commercial Officer
MT
05/19ACACIA PHARMA  : Appoints Debra Hussain as Chief Commercial Officer
AQ
05/12PRESS RELEASE : ???????paion ag publishes group quarterly statement for the firs..
DJ
05/04ACACIA PHARMA  : Announces Early Repayment of Loan Facility from Hercules Techno..
PU
05/04ACACIA PHARMA  : Announces Early Repayment of Loan Facility from Hercules Techno..
AQ
04/21ACACIA PHARMA  : Becomes New Industry Supporter of the American Society of Anest..
AQ
04/07PRESS RELEASE : Paion announces product launch of byfavo (remimazolam) in south ..
DJ
03/31ACACIA PHARMA  : Publication of Annual Report and Financial Statements for the Y..
AQ
03/30ACACIA PHARMA  : Publication of Annual Report and Financial Statements for the Y..
PU
03/30ACACIA PHARMA  : Publication of Annual Report 2020
AQ
03/29ACACIA PHARMA  : Annual Report and Financial Statements for the Year ended 31 De..
PU
03/29COSMO PHARMACEUTICALS N  : Full-year report 2020
AQ
More news
News in other languages on ACACIA PHARMA GROUP PLC
06/07Brussel herwint terrein
05/27Brusselse beurs fractioneel lager geopend
05/25BRUSSELS STOCK EXCHANGE : Stabiel slot Bel20
05/25Brussel rustig omhoog
05/25Rustige ochtend in Brussel
More news
Chart ACACIA PHARMA GROUP PLC
Duration : Period :
Acacia Pharma Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACACIA PHARMA GROUP PLC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 682,90 GBX
Last Close Price 184,58 GBX
Spread / Highest target 270%
Spread / Average Target 270%
Spread / Lowest Target 270%
EPS Revisions
Managers and Directors
NameTitle
Michael Bolinder Chief Executive Officer & Executive Director
Gary G. Gemignani Chief Financial Officer
Scott A. Byrd Chairman
Gabriel Fox Chief Medical Officer
John Robert Brown Senior Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ACACIA PHARMA GROUP PLC-18.71%259
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857